- Home
- MAIA vs SURG Comparison
MAIA vs SURG Comparison
Compare MAIA & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- SURG
- Stock Information
- Founded
- MAIA 2018
- SURG 2006
- Country
- MAIA United States
- SURG United States
- Employees
- MAIA N/A
- SURG N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- SURG Advertising
- Sector
- MAIA Health Care
- SURG Consumer Discretionary
- Exchange
- MAIA Nasdaq
- SURG Nasdaq
- Market Cap
- MAIA 56.3M
- SURG 64.1M
- IPO Year
- MAIA 2022
- SURG N/A
- Fundamental
- Price
- MAIA $1.70
- SURG $2.94
- Analyst Decision
- MAIA
- SURG Strong Buy
- Analyst Count
- MAIA 0
- SURG 1
- Target Price
- MAIA N/A
- SURG $9.00
- AVG Volume (30 Days)
- MAIA 468.1K
- SURG 68.8K
- Earning Date
- MAIA 08-08-2025
- SURG 08-12-2025
- Dividend Yield
- MAIA N/A
- SURG N/A
- EPS Growth
- MAIA N/A
- SURG N/A
- EPS
- MAIA N/A
- SURG N/A
- Revenue
- MAIA N/A
- SURG $40,029,467.00
- Revenue This Year
- MAIA N/A
- SURG $57.76
- Revenue Next Year
- MAIA N/A
- SURG $112.61
- P/E Ratio
- MAIA N/A
- SURG N/A
- Revenue Growth
- MAIA N/A
- SURG N/A
- 52 Week Low
- MAIA $1.40
- SURG $1.05
- 52 Week High
- MAIA $3.74
- SURG $3.47
- Technical
- Relative Strength Index (RSI)
- MAIA 44.78
- SURG 46.76
- Support Level
- MAIA $1.64
- SURG $2.86
- Resistance Level
- MAIA $1.74
- SURG $3.13
- Average True Range (ATR)
- MAIA 0.09
- SURG 0.15
- MACD
- MAIA -0.01
- SURG -0.02
- Stochastic Oscillator
- MAIA 11.76
- SURG 13.56
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.